Quest Diagnostics Incorporated

DGX

US74834L1008

Healthcare Facilities & Services

Market Closed - Nyse Other stock markets 04:00:02 2024-05-15 pm EDT			5-day change	1st Jan Change
140.8 ^USD	+1.16%		+3.41%	+2.10%

May. 15	Quest Diagnostics Keeps Quarterly Cash Dividend at $0.75 a Share, Payable on July 22 to Shareholders of Record on July 8	MT
May. 15	Argus Raises Quest Diagnostics' Price Target to $163 From $155	MT

Quest Diagnostics Incorporated Announces Executive Changes

October 20, 2022 at 06:45 am EDT

Quest Diagnostics Incorporated appointed Jim Davis as President on November 1, 2022. Mr. Rusckowski will remain as Executive Chairman through March 2023.

Latest news about Quest Diagnostics Incorporated

Quest Diagnostics Keeps Quarterly Cash Dividend at $0.75 a Share, Payable on July 22 to Shareholders of Record on July 8	May. 15	MT
Argus Raises Quest Diagnostics' Price Target to $163 From $155	May. 15	MT
Quest Diagnostics Appoints Murali Balakumar as Senior Vice President and Chief Information and Digital Officer	May. 06	CI
Quest Diagnostics to Acquire PathAI Diagnostics Assets in Collaboration Deal	May. 01	MT
Quest Diagnostics Forms Licensing Agreements with PathAI	May. 01	CI
Baird Adjusts Quest Diagnostics' Price Target to $144 From $138	Apr. 30	MT
US FDA publishes final rule for laboratory developed tests	Apr. 29	RE
Labcorp beats quarterly estimates on strong testing demand	Apr. 25	RE
Jefferies Adjusts Price Target on Quest Diagnostics to $160 From $155	Apr. 24	MT
UBS Adjusts Price Target on Quest Diagnostics to $146 From $139, Maintains Neutral Rating	Apr. 24	MT
Barclays Raises Quest Diagnostics' Price Target to $144 From $138	Apr. 24	MT
Deutsche Bank Adjusts Quest Diagnostics Price Target to $136 From $125, Maintains Hold Rating	Apr. 24	MT
Mizuho Adjusts Quest Diagnostics' Price Target to $155 From $150	Apr. 24	MT
Citigroup Adjusts Quest Diagnostics Price Target to $145 From $135	Apr. 24	MT
Leerink Partners Adjusts Quest Diagnostics Price Target to $141 From $135	Apr. 24	MT
Truist Raises Price Target on Quest Diagnostics to $150 From $145, Cites 'Strong Start' to 2024, Keeps Hold Rating	Apr. 24	MT
Evercore ISI Raises Quest Diagnostics Price Target to $145 from $140	Apr. 23	MT
Sector Update: Health Care Stocks Steady Pre-Bell Tuesday	Apr. 23	MT
Transcript : Quest Diagnostics Incorporated, Q1 2024 Earnings Call, Apr 23, 2024	Apr. 23
Quest Diagnostics Posts Flat Q1 Adjusted Earnings, Revenue Rises; 2024 Earnings, Revenue Guidance Raised	Apr. 23	MT
Earnings Flash (DGX) QUEST DIAGNOSTICS Reports Q1 Revenue $2.37B, vs. Street Est of $2.29B	Apr. 23	MT
Earnings Flash (DGX) QUEST DIAGNOSTICS Posts Q1 EPS $2.04, vs. Street Est of $1.86	Apr. 23	MT
Quest Diagnostics Incorporated Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 23	CI
Quest Diagnostics Incorporated Updates Earnings Guidance for the Full Year of 2024	Apr. 23	CI
MORNING BID AMERICAS-Tanking Tesla reports, Europe business beats	Apr. 23	RE

Chart Quest Diagnostics Incorporated

Duration

Period

More charts

Quest Diagnostics is the world's leading provider of diagnostics testing and information service for patients and health professionals. Net sales break down by activity as follows: - testing and diagnostic services (97.3%): routine clinical testing, gene-based testing and advanced diagnostic and anatomica pathology diagnostic services; - other (2.7%).

Sector

Healthcare Facilities & Services

Calendar

10:30am - Annual General Meeting

Related indices

S&P 500

More about the company

Income Statement Evolution

More financial data

Ratings for Quest Diagnostics Incorporated

Trading Rating

Investor Rating

ESG Refinitiv

A-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

139.2 USD

Average target price

146.7 USD

Spread / Average Target

+5.44%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Healthcare Facilities & Services

	1st Jan change	Capi.
QUEST DIAGNOSTICS INCORPORATED	+2.10%	15.46B
CVS HEALTH CORPORATION	-28.75%	70.3B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY	+2.04%	27.46B
LABORATORY CORPORATION OF AMERICA HOLDINGS	-6.19%	17.8B
FRESENIUS SE & CO. KGAA	+2.32%	17.46B
REDE D'OR SÃO LUIZ S.A.	+7.06%	13.49B
FRESENIUS MEDICAL CARE AG	+10.80%	13.06B
NATERA, INC.	+71.31%	12.96B
TENET HEALTHCARE CORPORATION	+75.96%	12.56B
EUROFINS SCIENTIFIC SE	+1.87%	12.14B

Other Healthcare Facilities & Services